Nutritional Agents : Replenishers & Regulators of Water & Electrolytes
IKCL2 “KCL injection”
Each ml contains potassium chloride 150 mg, riboflavin phosphate sodium 0.3 mg; 10 ml/amp(20 mEq/10 ml)
IKCL9 “0.298% KCl in 0.9% NaCl Injection”
Each ml contains potassium chloride 2.98 mg; 500 ml/bot(40 mEq/L)
適應症：
IKCL2：鉀攝取量不足而引起之低鉀血症、重症鹼中毒症、鉀離子高度損失時之鉀離子補給。
IKCL9：治療鉀缺乏症。
Usual dose:
Hypokalemia: PO
Adult (serum K 3-3.5 mEq/L): 40-100 mEq/day divided into 2-3 doses (< 20 mEq/dose).
Pediatric: 2-5 mEq/kg/day in divided doses.
Precaution:
Addison’s disease, untreated; adynamia episodica hereditaria; concomitant use of ACE inhibitors or potassium-sparing diuretics, dehydration, digitalis-induced atrioventricular conduction disturbances, heat cramps, severe renal impairment, sickle cell disease.
Adverse effect:
Common: diarrhea, flatulence, nausea, vomiting.
Serious: abdominal pain, cardiac arrest, ECG changes, GI ulceration, hyperkalemia.